TY  - CONF

T1  - Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion

JO  - Value in Health

UR  - https://eprints.whiterose.ac.uk/id/eprint/111902

UR  - https://doi.org/10.1016/j.jval.2016.09.116

PY  - 2016/10/31

AU  - Goodall M

AU  - Tosh J

AU  - Alshreef AO

AU  - Tappenden P

ED  - 

DO  - DOI: 10.1016/j.jval.2016.09.116

PB  - Elsevier

VL  - 19

IS  - 7

Y2  - 2025/11/23

ER  -